9.68% upside for Core Scientific stock — short-term sellers hold control despite sharp rally

9.68% upside for Core Scientific stock — short-term sellers hold control despite sharp rally
Core Scientific surges 9.68% to $16.26

Core Scientific Inc. (CORZ) is trading at $16.26, below both its MA-20 ($17.98) and MA-50 ($16.79), but above the MA-200 ($15.01). This reflects persistent selling pressure in the short and medium term, while maintaining a supportive longer-term structure above last year's levels.

CORZ price prediction
24H 0.9%
$27.99
48H 0.11%
$27.77
7D 0.43%
$27.86
1M 19.21%
$33.07
3M 31.36%
$36.44
6M 137.78%
$65.96
12M 111.32%
$58.62
Current price: $ 27.74 0.5200 1.91%
Closed 06/12
Daily range 27.49 Arrow from to Icon 28.34
Weekly range 25.24 Arrow from to Icon 28.57
Loading...

Highlights

  • Core Scientific trades at $16.26, below its MA-20 ($17.98) and MA-50 ($16.79), but above MA-200 ($15.01), signaling persistent short- and medium-term selling pressure.
  • Key support is established around the MA-200 ($15.01) with dynamic resistance at the Ichimoku Kijun ($17.26), anchoring the likely price consolidation range.
  • Momentum oscillators, including RSI (33.14) and Stochastic RSI (0.00), are deeply oversold, and technicals imply less than a 20% chance of further upside over the next five days.

Oversold bearish momentum contrasts with intraday gap and rebound

Technically, the nearest dynamic resistance is the Ichimoku Kijun at $17.26, with solid support developing around the MA-200 at $15.01. Momentum signals remain mixed: the MACD and ADX show neutral indications, pointing to a lack of strong trend direction on the daily chart. Oscillators such as the RSI (33.14), Stochastic RSI (0.00), CCI (−231.22), and notably negative Bull/Bear Power (−1.22) all point to ongoing seller dominance in momentum. Despite today’s session opening with a gap up from $14.82 to $15.60 and a 9.68% surge near session highs within a $15.60–$16.34 band, oscillators remain oversold and bearish, highlighting the divergence with sharp intraday gains.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Sideways consolidation likely as upward breakout odds decline

For the next five trading days, the typical volatility band is forecast in the $14.65–$17.90 range. With the probability of further price increases remaining very low (less than 20%), a decline is more likely, and price action will probably consolidate sideways between long-term support at $15.01 and resistance near $17.26 as indicated by closely clustered moving averages and Ichimoku levels. A sustained move above $17.26 would be needed for a bullish turn, while a break below $15.01 could drive renewed bearish momentum.

Anton Kharitonov, expert at Traders Union, sees lingering downside pressure on Core Scientific Inc. as price action remains capped below $17.26. He notes that momentum and oscillator readings confirm ongoing seller dominance, while technical structure above MA-200 keeps longer-term support intact. Kharitonov remains cautious given mixed signals and low breakout odds in the coming sessions. "The base case remains for sideways action between $15.01 and $17.26 — I won’t trust any upside until resistance is reclaimed with conviction."

Previously it was reported that Core Scientific Inc is exhibiting short-term and medium-term selling pressure as it trades below its 20-day and 50-day moving averages, though it remains well above the 200-day average, confirming a bullish long-term trend structure. Momentum indicators are mixed—with a bullish daily MACD offset by weak ADX and oversold oscillators—while support is identified near $14.92 and resistance around $17.26, indicating likely consolidation within a defined price band as technical exhaustion develops.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.